UNLABELLED: Bipolar disorder is a cyclic and polymorphic disease. Patients may show manic, hipomanic, depressive or mixed symptoms, and they may be in partial or complete remission. For this reason, the assessment of the course, severity and outcome of the disorder is very complex. Most of the available psychometric instruments have been designed for the assessment of acute episodes of specific polarity. METHODS: We present the modified version of the Clinical Global Impression for Bipolar Disorder (CGI-BP-M) a condensed version of the CGI-BP, which is also an adaptation of the CGI for bipolar patients. RESULTS: The CGI-BP-M takes only a few minutes to complete, and it has proved to be useful in the assessment of the short and long-term efficacy of several treatments such as olanzapine and quetiapine. Significant improvements in several subescales of the CGI-BP-M after treatment with these compounds are shown. CONCLUSIONS: The CGI-BP-M, a user-friendly scale for the assessment of manic, hypomanic, depressive or mixed symptoms, and long-term outcome of bipolar disorder, is a useful tool for the assessment of the efficacy of several treatments.
UNLABELLED: Bipolar disorder is a cyclic and polymorphic disease. Patients may show manic, hipomanic, depressive or mixed symptoms, and they may be in partial or complete remission. For this reason, the assessment of the course, severity and outcome of the disorder is very complex. Most of the available psychometric instruments have been designed for the assessment of acute episodes of specific polarity. METHODS: We present the modified version of the Clinical Global Impression for Bipolar Disorder (CGI-BP-M) a condensed version of the CGI-BP, which is also an adaptation of the CGI for bipolarpatients. RESULTS: The CGI-BP-M takes only a few minutes to complete, and it has proved to be useful in the assessment of the short and long-term efficacy of several treatments such as olanzapine and quetiapine. Significant improvements in several subescales of the CGI-BP-M after treatment with these compounds are shown. CONCLUSIONS: The CGI-BP-M, a user-friendly scale for the assessment of manic, hypomanic, depressive or mixed symptoms, and long-term outcome of bipolar disorder, is a useful tool for the assessment of the efficacy of several treatments.
Authors: Rodolfo N Campos; Luis F Costa; Danielle S Bio; Márcio G Soeiro de Souza; Carla R L Garcia; Frederico N Demétrio; Doris H Moreno; Ricardo A Moreno Journal: Trials Date: 2010-06-23 Impact factor: 2.279
Authors: Chantal Henry; Ole A Andreassen; Angelo Barbato; Jacques Demotes-Mainard; Guy Goodwin; Marion Leboyer; Eduard Vieta; Willem A Nolen; Lars Vedel Kessing; Jan Scott; Michael Bauer Journal: Int J Bipolar Disord Date: 2013-04-17
Authors: Ana Moreno-Alcázar; Joaquim Radua; Ramon Landín-Romero; Laura Blanco; Mercè Madre; Maria Reinares; Mercè Comes; Esther Jiménez; Jose Manuel Crespo; Eduard Vieta; Victor Pérez; Patricia Novo; Marta Doñate; Romina Cortizo; Alicia Valiente-Gómez; Walter Lupo; Peter J McKenna; Edith Pomarol-Clotet; Benedikt L Amann Journal: Trials Date: 2017-04-04 Impact factor: 2.279
Authors: María Aliño-Dies; Joan Vicent Sánchez-Ortí; Patricia Correa-Ghisays; Vicent Balanzá-Martínez; Joan Vila-Francés; Gabriel Selva-Vera; Paulina Correa-Estrada; Jaume Forés-Martos; Constanza San-Martín Valenzuela; Manuel Monfort-Pañego; Rosa Ayesa-Arriola; Miguel Ruiz-Veguilla; Benedicto Crespo-Facorro; Rafael Tabarés-Seisdedos Journal: Front Psychol Date: 2020-11-25